Skip to NavigationSkip to content

News

According to new data from intelligence provider GBI Research, the flu vaccines market in the Asia-Pacific (APAC) region is set to grow from $1.24...
A new study has estimated that one in four men could avoid unnecessary invasive biopsies to detect prostate cancer by utilising advanced MRI...
Johnson & Johnson’s Imbruvica (ibrutinib) has scored its fifth indication approval in the US for the treatment of Marginal Zone Lymphoma (MZL...
Check out the Top Ten most popular articles on Pharmafile.com this week!
Jenny Tragner, director at R&D tax credit consultancy ForrestBrown and member of the UK R&D Consultative Committee discusses the importance...
Sanofi’s diabetes drug Suliqua has been granted marketing authorisation by the European Commission.
Boehringer Ingelheim has just stepped into the ring to battle it out for a slice of Humira’s revenue with accepted filings to the FDA and EMA for...
GlaxoSmithKline has announced that its global head of pharmaceuticals Abbas Hussain is leaving the company; the vacated role will then be filled by...
Allergan has been fined $15 million by the SEC after committing disclosure violations during merger talks with “potentially friendlier merger...
Eli Lilly has announced it is to shell out $960 million to snatch up CoLucid Pharmaceuticals to reclaim migraine drug lasmiditan after it licensed...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches